Prevalence and associated factors of dyslipidemia among adults with coexisting chronic disease in Ethiopia: A systematic review and meta-analysis
Open Access
- 29 April 2025
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (4) , e0320119
Abstract
Introduction: Dyslipidemia is a well-established, modifiable risk factor for cardiovascular disease. This study aimed to determine the pooled prevalence of dyslipidemia, its components, and associated factors among adult patients residing in Ethiopia. Method: A comprehensive search of articles was conducted using MEDLINE, Embase, African Journals Online, Google Scholar, and University repositories. The quality of the studies was evaluated using the Joanna Briggs Institute quality appraisal criteria. Dyslipidemia was defined based on the National Cholesterol Education Program Adult Treatment Panel III cut-off points. We pooled the effect sizes using a random-effects model in Stata (v.16). Subgroup and sensitivity analysis were also performed. Small study effect was assessed by Luis Furuya-Kanamori asymmetry index, Doi plot, funnel plot, and Egger’s tests. Results: Out of 640 initially identified articles, 104 underwent full-text review, and 62 met the inclusion criteria for the final analysis. The pooled prevalence of overall dyslipidemia was 64% (95% CI: 54–74%; I2 = 98.74; P < 0.001). The prevalence of elevated total cholesterol was 32% (95% CI: 27–36%; I2 = 97.09; P < 0.001), elevated total triglycerides was 43% (95% CI: 38–47%; I2 = 97.56; P < 0.001), elevated low-density lipoprotein was 30% (95% CI: 24–36%; I2 = 97.24; P < 0.001), and low high-density lipoprotein was 48% (95% CI: 42–54%; I2 = 98.53; P < 0.001). Having high wrist circumference, older age, being overweight or obese, residing in urban, being an alcohol consumer, being a smoker, and being physically inactive were associated with increased odds of dyslipidemia. Conclusion: Dyslipidemia prevalence is alarmingly high among adults with coexisting chronic diseases in Ethiopia, posing a significant public health challenge. Regular screening, early detection, and prompt management of dyslipidemia are critical to addressing this issue.Keywords
This publication has 95 references indexed in Scilit:
- Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)Progress in Cardiovascular Diseases, 2023
- The association of Helicobacter Pylori infection with dyslipidaemia and other atherogenic factors in dyspeptic patients at St. Paul's Hospital Millennium Medical CollegeHeliyon, 2022
- Prevalence and predictors of dyslipidemia among hypertensive patients in Lumame Primary Hospital, Amhara, Ethiopia: A cross-sectional studyMetabolism Open, 2021
- Magnitude of metabolic syndrome and its predictors among patients on second-generation antipsychotic drugs at six psychiatry clinics and mental hospitals, in Addis Ababa, Ethiopia, 2019; Multicenter cross-sectional studyDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021
- The global magnitude of metabolic syndrome among antiretroviral therapy (ART) exposed and ART-naïve adult HIV-infected patients in gedio-zone, southern Ethiopia: Comparative cross-sectional study, using the Adult Treatment Panel III criteriaDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019
- Metabolic syndrome and associated factors among psychiatric patients in Jimma University Specialized Hospital, South West EthiopiaDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018
- Burden of metabolic syndrome among HIV-infected patients in Southern EthiopiaDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2014
- Arterial stiffness and influences of the metabolic syndrome: A cross-countries studyAtherosclerosis, 2014
- HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of riskAtherosclerosis, 2009
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001